Cancela R, Mendez P, Padilla MC, Novales SCJ, González GG, González SE

Language: Spanish
References: 24
Page: 26-30
PDF size: 78.96 Kb.

ABSTRACT

We report a case of disseminated cryptococcosis caused by Cryptococcus neoformans is presented in a male who had AIDS and Kaposi´sarcoma (KS) . KS is the most frequent neoplasm in patients with acquired immunodeficiency syndrome (AIDS). Although AIDS associated cryptococcosis affects highly immunosuppressed people early diagnosis and treatment may be successful.

REFERENCES

1. Martineli P, Tyring SK. Human herpesvirus 8 dermatologic clinics 2002; 20.

2. Sarid R. Virology, Pathogenesis and associated Kaposi-sarcoma. Mayo Clin Proc 2002; 77: 941-49.

3. Garman ME, Tyring SK. The cutaneous manifestations of HIV infection. Dermatologic Clinics 2002, 20.

4. Trent JT, Kirsner RS. Cutaneous manifestations of HIV: A primer. Advances in Skin & Wound Care 2004; 17: 116-127.

5. Costner M, Cockerell CJ. The changing spectrum of the cutaneous manifestations of HIV disease. Arch Dermatol 1998; 134: 1290-1292.

6. Kwonn, Therapy of AIDS-associated Kaposi´s sarcoma: targeting pathogenetic mechanisms Hematology oncology. Clinics of North America 2003; 17.

7. Ochoa G, Catn L, Ortiz E et al. Criptococosis cutánea como forma de inicio de criptococosis diseminada. Actas Dermo-Sifilográficas 1990; 9: 561-62.

8. Saúl A, Lavalle P, Rodríguez G. Cutaneous cryptococcosis. Inter Soc Trop Dermatol 1980; 14: 457-60.

9. Durden F, Elewsi B, Cleveland M. Cutaneous involvement with Cryptococcus neoformans in AIDS. J Am Acad Dermatol 1994; 5: 844-48.

10. Perfect J, Casadevall A. Cryptococcosis. Infect Dis Clin N Am 2002; 16.

11. Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immunol 1995; 63: 1725-31.

12. Kawakami K, Tohyama M, Teruya K. Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol Med Microbiol 1996; 13: 133-40.

13. Rodríguez F, Roson E, Pereiro M et al. Criptococosis cutánea en dos pacientes con síndrome de inmunodeficiencia adquirida. Actas Dermo-Sifilográficas 1996; 87: 395-399.

14. Goonetilleke A, Krause K, Slater D et al. Primary cutaneous cryptococcosis in an immunocompromized pigeon Keeper. Br J Dermatol 1995; 133: 650-52.

15. Manfred R, Mazzzoni A, Nenetti A et al. Morphologic features and clinical significance of skin involvement in patients with AIDS-related cryptococcosis 1996; 76: 72-74

16. Porras B, Costner M, Friedman A. Update on cutaneous manifestation of HIV infection. Medical Clinics of North America 1998; 82: 1033-79.

17. Azon A, González J, Pedrol E et al. Herpetiform and mollusca contagiosa-like cutaneous cryptococcosis in a patient with AIDS. Arch Dermatol 1988; 7: 665-67.

18. Sánchez B, Rodríguez J, Romero G, Alonso J, Iglesias L. Cryptococcal cellulitis in an immunocompetent host. American Academy of Dermatology 1997; 36: 109-115.

19. Dimino L, Gurevitch A. Cutaneous manifestations of disseminated cryptococcosis. J Am Acad Dermatol 1995; 32: 844-850.

20. Rico M, Penneys N. Cutaneous cryptococcosis resembling molluscum contagiosum in a patient with AIDS. Arch Dermatol 1985; 121: 901-902.

21. Grant H, Armstrong D. Fungal infections in AIDS-cryptococcosis. Infect Dis Clin North Am 1988; 2: 457-62.

22. Hernández A. Cutaneous Cryptococcosis. Dermatol Clin 1989; 7: 269-74.

23. Elder D. Lever Histopatología de la piel. 8ª edición. Ed. Interamericana. Argentina 1999: 479-480.

24. Saag M, Graybill R, Larsen R et al. Practice guidelines for the management of cryptococcal disease. Clin Infec Dis 2000; 30: 715-33.